Significant reduction in proteinuria after treatment with tafamidis

Amyloid. 2019;26(sup1):67-68. doi: 10.1080/13506129.2019.1583186.

Authors

Asuncion Ferrer-Nadal¹, Tomas Ripoll², Mercedes Uson³, Antoni Figuerola³, Hernan Andreu⁴, Ines Losada⁵, Juan Gonzalez⁵, Eugenia Cisneros-Barroso⁵, Juan Buades⁵

Affiliations

¹ a Department of Nephrology, Hospital Son Llatzer , Palma de Mallorca , Spain.
² b Department of Cardiology, Son Llatzer Hospital , Palma de Mallorca , Spain.
³ c Department of Neurology, Son Llatzer Hospital , Palma de Mallorca , Spain.
⁴ d Department of Gastroenterology, Son Llatzer Hospital, Digestive Medicine , Palma de Mallorca , Spain.
⁵ e Department of Internal Medicine, Hospital Son Llàtzer , Palma de Mallorca , Spain.

PMID: 31343359
DOI: 10.1080/13506129.2019.1583186

No abstract available

MeSH terms

Albuminuria / urine
Amyloid Neuropathies, Familial / drug therapy*
Amyloid Neuropathies, Familial / genetics
Amyloid Neuropathies, Familial / urine
Benzoxazoles / administration & dosage*
Benzoxazoles / adverse effects
Creatinine / urine
Humans
Mutation
Prealbumin / genetics*
Proteinuria / urine

Substances

Benzoxazoles
Prealbumin
tafamidis
Creatinine

Supplementary concepts

Amyloidosis, Hereditary, Transthyretin-Related